Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Trading Update

24 Nov 2016 07:00

RNS Number : 0036Q
Quixant PLC
24 November 2016
 

24 November 2016

Quixant plc

("Quixant" or the "Group")

 

Trading Update

 

Quixant (AIM: QXT), a leading provider of innovative, highly engineered technology products principally to the global gaming industry, is pleased to provide the following update on current trading ahead of the year ending 31 December 2016.

The Group's progress has accelerated in the second half of the year with the Gaming Division in particular showing strong year on year revenue growth. Increased demand for Quixant's computer platforms for the gaming industry was evident from several customers. As a result the Board now expects EBITDA margins in H2 to be higher than previously anticipated, and significantly higher than the EBITDA margins achieved in H1.

The Board now anticipates that total revenue for the year will be not less than $86m and profit will be ahead of market expectations.

Nick Jarmany, CEO of Quixant commented: "We have had a very strong second half to the year with demand for our computer platforms building through the period. Couple this with a very satisfactory performance from Densitron, who we acquired at the end of last year, and we are very pleased with the overall performance of the Group."

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

For further information please contact:

 

Quixant plc

Tel: +44 (0)1223 892 696

Nick Jarmany, Chief Executive

 

Jon Jayal, Chief Operating Officer

 

 

 

Nominated Adviser and Broker:

 

finnCap

Tel: +44(0)20 7220 0500

Matt Goode / Grant Bergman / Simon Hicks (Corporate Finance)

 

Simon Johnson /Alice Lane (Corporate Broking)

 

 

 

Financial PR:

Tel: +44(0)20 8004 4218

Alma PR

 

John Coles

 

Hilary Buchanan 

 

   

 

 

About Quixant

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally to the global gaming industry. The Company is headquartered in Cambridge in the UK where the global sales function is based. North America sales and sales support is run from their subsidiary in Las Vegas. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support team based in Italy. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP much of which is copyright protected.

 

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets.

 

In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLXLLLQFFXFBF
Date   Source Headline
10th Dec 20209:00 amRNSPrice Monitoring Extension
10th Dec 20207:00 amRNSTrading Update
17th Nov 20205:52 pmRNSHolding(s) in Company
27th Oct 20207:00 amRNSExercise of Options
14th Oct 20206:15 pmRNSHolding(s) in Company
13th Oct 20207:00 amRNSDirector Shareholding
12th Oct 20203:17 pmRNSGrant of Options
7th Oct 20205:26 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSInterim Results
19th Aug 20207:00 amRNSAppointment of Interim CFO
10th Aug 20207:00 amRNSChanges to the Board of Directors
23rd Jul 20204:45 pmRNSHolding(s) in Company
23rd Jul 20204:05 pmRNSHolding(s) in Company
22nd Jul 20207:00 amRNSTrading Update and Notice of Results
3rd Jul 20205:57 pmRNSHolding(s) in Company
3rd Jul 20205:57 pmRNSHolding(s) in Company
19th May 20204:21 pmRNSResult of AGM
19th May 20207:00 amRNSTrading Update
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:35 pmRNSPrice Monitoring Extension
29th Apr 20204:42 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSDirector/PDMR Shareholding
27th Apr 20207:00 amRNSDesignate Director Shareholding
23rd Apr 20207:00 amRNSAppointment of Non-Executive Director
6th Apr 20207:00 amRNSAudited Final Results
3rd Apr 202012:23 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNS2019 Trading and COVID-19 update
27th Mar 20203:08 pmRNSTiming of Results
26th Mar 20204:50 pmRNSBoard Change
19th Mar 202012:50 pmRNSHolding(s) in Company
18th Mar 20207:00 amRNSNotice of Results Update
12th Feb 20205:44 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading Update and Notice of Results
20th Dec 20195:50 pmRNSHolding(s) in Company
24th Oct 20194:13 pmRNSDirector/PDMR Shareholding
22nd Oct 20193:05 pmRNSHolding(s) in Company
22nd Oct 20193:05 pmRNSHolding(s) in Company
14th Oct 20194:10 pmRNSDirector/PDMR Shareholding
7th Oct 20195:14 pmRNSDirector/PDMR Transfer Shareholding
27th Sep 20193:41 pmRNSHolding(s) in Company
23rd Sep 20193:09 pmRNSDirector/PDMR Shareholding
19th Sep 20194:13 pmRNSDirector/PDMR Shareholding
18th Sep 20194:54 pmRNSDirector/PDMR Shareholding
17th Sep 20199:05 amRNSSecond Price Monitoring Extn
17th Sep 20199:00 amRNSPrice Monitoring Extension
17th Sep 20197:00 amRNSInterim Results
23rd Jul 20197:00 amRNSTrading Update and Notice of Results
22nd Jul 201911:54 amRNSExercise of Options
4th Jul 20197:00 amRNSCompany Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.